Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company's Board of Directors
Globenewswire· 2025-07-17 12:15
Core Insights - Royalty Pharma plc has appointed Carole Ho and Elizabeth (Bess) Weatherman to its Board of Directors, enhancing its leadership team with expertise in biopharmaceuticals and finance [1][2][3] Group 1: Board Appointments - Carole Ho is the Chief Medical Officer and Head of Development at Denali Therapeutics, with 20 years of experience in biopharma, previously serving as Vice President of Clinical Development at Genentech [2][3] - Bess Weatherman has 35 years of experience as an investor in the healthcare industry and is currently a Special Limited Partner at Warburg Pincus, having joined the firm in 1988 [3] Group 2: Company Overview - Royalty Pharma, founded in 1996, is the largest buyer of biopharmaceutical royalties and a key funder of innovation in the biopharmaceutical sector, collaborating with various innovators [4] - The company has a portfolio that includes royalties on over 35 commercial products and 16 development-stage product candidates, indicating a strong position in the market [4] Group 3: Corporate Governance - The appointment of the new board members increases independent representation on the board to over 90%, reflecting Royalty Pharma's commitment to enhanced corporate governance [5]
Enlightify Inc. Announces Strategic Investment in Cyber Token, Emphasizing Long-Term Commitment to Web3 Infrastructure
Globenewswire· 2025-07-17 12:10
Core Insights - Enlightify Inc. announced a strategic investment of up to $20 million in Cyber, a leading blockchain ecosystem focused on decentralized AI and social infrastructure [1] - The investment aligns with Enlightify's diversification strategy and aims to create long-term value for shareholders while participating in the growing digital asset ecosystem [1][2] - Cyber's current market capitalization is approximately $71 million, with a total supply of 100 million tokens [4] Investment Strategy - Enlightify plans to acquire Cyber tokens in stages over the next 12 months, utilizing a dollar-cost averaging strategy to manage short-term price volatility [2] - The purchased Cyber tokens will be classified as digital assets and held as a long-term investment, with performance reviews conducted regularly [3] Cyber Overview - Cyber operates a blockchain ecosystem that builds AI and decentralized social infrastructure, with its native CYBER token used for governance, staking rewards, and ecosystem incentives [4][6] - Cyber Network is an Ethereum Layer-2 optimized for social applications, integrating AI to enhance the Web3 user experience [6] - The decentralized social networking sector is expected to experience rapid growth due to increasing awareness of data ownership and the adoption of Web3 technologies [6]
Maris-Tech to Showcase Diamond AI-Powered Situational Awareness Platform at GVSETS 2025
Globenewswire· 2025-07-17 12:10
Core Insights - Maris-Tech Ltd. is showcasing its AI-powered situational awareness platform, Diamond, at the Ground Vehicle Systems Engineering and Technology Symposium (GVSETS) in Michigan from August 12-14, 2025, emphasizing its commitment to the U.S. defense market [1][4]. Company Overview - Maris-Tech is a global leader in video and AI-based edge computing technology, specializing in intelligent video transmission solutions that address complex encoding-decoding challenges [5]. - The company offers lightweight, low-power products that provide high-performance capabilities, including raw data processing, seamless transfer, advanced image processing, and AI-driven analytics [5]. - Founded by veterans of the Israeli technology sector, Maris-Tech serves major manufacturers in defense, aerospace, intelligence gathering, homeland security, and communication industries [5]. Product Features - The Diamond platform enables real-time detection, tracking, and classification of ground and airborne threats, enhancing the survivability of armored fighting vehicles (AFVs) in both urban and open terrain [3]. - The platform is designed for seamless integration with both legacy and next-generation armored systems, showcasing its versatility in various combat environments [3].
Vital Farms Achieves Major Farm Network Expansion Milestone, Surpasses 500 Family Farms
Globenewswire· 2025-07-17 12:05
AUSTIN, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today announced a major milestone within its farm network, now surpassing 500 family farms versus 300 at the end of 2023. To meet the strong demand for its eggs, Vital Farms has continued to raise the standards in attracting and retaining family farmers across the Pasture Belt™ to produce the leading U.S. brand of pasture-raised eggs by retail dol ...
60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria
Globenewswire· 2025-07-17 12:01
Study will evaluate activity of tafenoquine against vector-borne pathogens, Borrelia (Lyme disease) and Bartonella in cell cultureBorrelia and Bartonella, together with Babesia, represent the "3Bs," pathogens most often present in individuals with tick-borne illness such as Lyme disease WASHINGTON, July 17, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, toda ...
SunPower to Report 2Q’25 Results July 22, 2025
Globenewswire· 2025-07-17 12:00
Core Viewpoint - SunPower is set to release its quarterly investor report on July 22, 2025, and the CEO expresses confidence in the company's profitability despite industry challenges [1][2]. Company Performance - SunPower will report its Q2 2025 results, marking the second consecutive quarter of operating profit after a four-year profit drought [2]. - The company has been invited to join the Russell 3000 and Russell Microcap indices, which may help improve its market reputation [2]. Industry Context - The solar industry is facing challenges due to recent ITC (Investment Tax Credit) issues, but the CEO remains optimistic about SunPower's ability to thrive in a more competitive solar market [2]. - There are concerns regarding the negative portrayal of SunPower in media outlets, particularly regarding outdated references to bankruptcy, which the company is actively trying to correct [2]. Company Overview - SunPower is a leading residential solar services provider in North America, offering digital platforms and installation services to support energy-efficient lifestyles [3].
Aemetis India Appoints Chief Financial Officer
Globenewswire· 2025-07-17 12:00
CUPERTINO, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and biofuels company, announced today that its India subsidiary, Universal Biofuels, appointed Anjaneyulu Ganji as Chief Financial Officer, commencing responsibilities on July 17, 2025. “The growing India economy has increased demand for energy, including biodiesel, ethanol, and compressed natural gas,” stated Sanjeev Duggal, Managing Director of Universal Biofuels. “To lead the expansion of Universal ...
ASP Isotopes Inc. Announces Updates on the Progress of Commercial Production at its Three Enrichment Facilities in South Africa
Globenewswire· 2025-07-17 12:00
WASHINGTON, July 17, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced several updates on the progress of commercial production at the Company’s three isotope enrichment facilities in Pretoria, South Africa as well as other corporate matters, in advance of a presentation by the Company’s Chairman and CEO ...
Asia Broadband - Phase 2 Production Line Processing Plant Equipment Received From China and On Track for Build-Out
Globenewswire· 2025-07-17 12:00
AABB Plant Equipment Image 1 AABB Plant Equipment Image 1 AABB Plant Equipment Image 2 AABB Plant Equipment Image 2 AABB Plant Equipment Image 3 AABB Plant Equipment Image 3 AABB Plant Equipment Image 4 AABB Plant Equipment Image 4 AABB Plant Equipment Image 5 AABB Plant Equipment Image 5 AABB Plant Equipment Image 6 AABB Plant Equipment Image 6 AABB Plant Equipment Image 7 AABB Plant Equipment Image 7 AABB Plant Equipment Image 8 AABB Plant Equipment Image 8 <p align ...
BioAtla Announces Upcoming Oral Presentation at the 2025 European Society for Medical Oncology (ESMO) TAT Asia Meeting
Globenewswire· 2025-07-17 12:00
SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company” or “BioAtla”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced an oral presentation at the upcoming 2025 European Society for Medical Oncology (ESMO) TAT Asia Meeting to be held in Hong Kong Sar, China from July 18–20, 2025. Oral Presentation Details: Title: First-in-human phase I st ...